Alan Wilson

SHL Medical AB develops and manufactures medical devices. The company offers services to pharmaceutical and biotech companies. It also operates in the United States of America and Taiwan. SHL Medical was founded in 1986 and is headquartered in Nacka Strand, Sweden

Part of IQVIA Holdings, Inc., Läkemedelsstatistik AB is a Swedish company that conducts research on pharmaceutical drug companies. The company is based in Stockholm, Sweden. Läkemedelsstatistik was acquired by IQVIA, Inc., part of IQVIA Holdings, Inc. from February 26, 2010 on December 31, 2006.

Cogmed develops and markets software-based working memory training products for improved attention. The company's products are a unique combination of breakthrough research, original software design and effective support methodology. Cogmed is a privately held company founded in Stockholm, Sweden in 2001. The founders are neuroscientists at the Karolinska Institute in Stockholm and game developers. The firm's main markets are the United States and Sweden. In 2006 Cogmed established its U.S. offices in Naperville and Illinois. Cogmed works with practices across the United States and Canada. It also has partners in Japan, in several European countries, and around the world. Cogmed is involved in evidence-based cognitive training. The firm has research results, scientifically validated, showing that Cogmed training provides substantial and lasting improvements in attention, for people with poor working memory, in all age groups. That makes Cogmed's products the best-validated products on the market.

Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives.

Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.

Redeye AB is an equity research and investment banking firm headquartered in Stockholm, Sweden. The firm was founded in 1999 and is a subsidiary of Redhold AB. It provides corporate clients and investors with research on technology based businesses in the Nordic countries that compete in the global arena. Redeye seeks companies with disruptive technologies or ability to leverage existing technology to create new market opportunities.